Puberty blockers and cross-sex hormones are experimental treatments and should be confined to clinical trials

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

2 Citations (Scopus)

2 Downloads (Pure)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{bfc0b44ee3af4107b8c62acec892050b,

title = "Puberty blockers and cross-sex hormones are experimental treatments and should be confined to clinical trials",

author = "Jilles Smids",

year = "2025",

month = nov,

day = "10",

doi = "10.1136/jme-2025-111378",

language = "English",

journal = "Journal of Medical Ethics",

issn = "0306-6800",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Puberty blockers and cross-sex hormones are experimental treatments and should be confined to clinical trials

AU - Smids, Jilles

PY - 2025/11/10

Y1 - 2025/11/10

UR - https://www.scopus.com/pages/publications/105021269814

U2 - 10.1136/jme-2025-111378

DO - 10.1136/jme-2025-111378

M3 - Comment/Letter to the editor

C2 - 41218917

AN - SCOPUS:105021269814

SN - 0306-6800

JO - Journal of Medical Ethics

JF - Journal of Medical Ethics

M1 - jme-2025-111378

ER -